Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 60601-2-62-15, titled Medical Electrical Equipment – Part 2-62: Particular Requirements for the Basic Safety and Essential Performance of High Intensity Therapeutic Ultrasound (HITU) Equipment, is the Canadian adoption of IEC 60601-2-62:2010, with national deviations. This standard applies to medical electrical equipment used for non-invasive therapeutic ultrasound treatments, specifically equipment that generates high-intensity focused ultrasound (HIFU) or similar ultrasound fields intended to produce thermal or mechanical effects in biological tissues.
HITU equipment is used in a range of clinical applications including tumor ablation, treatment of uterine fibroids, and other soft tissue conditions. The standard provides essential safety and performance requirements for these devices under normal and single-fault conditions, ensuring that the equipment does not present unacceptable risks to patients, operators, or the environment.
The scope includes all subsystems of the HITU equipment: the therapy applicator (transducer), the generator and control electronics, the cooling system (if integral), and the user interface. The standard also covers equipment intended to operate in conjunction with imaging guidance (ultrasound, MRI, or other modalities) that may be used for treatment planning and monitoring.
CAN CSA C22.2 No. 60601-2-62-15 modifies and supplements the general requirements of the IEC 60601-1 collateral standards. Below is a summary of the key technical requirements drawn from the standard’s clauses:
| Clause / Requirement | Description | Critical Limits / Thresholds |
|---|---|---|
| 201.12 – Output accuracy | Acoustic output power and intensity must be measured under defined conditions and must deviate by no more than ±20% from the set value at nominal operating conditions. | ±20% of indicated power; ±1 dB for intensity |
| 201.13 – Patient coupling verification | The equipment must detect adequate acoustic coupling between the applicator and patient; if coupling is insufficient, therapy energy delivery must be interrupted. | Coupling quality must be validated before and during delivery |
| 201.14 – Applicator surface temperature | Under normal use, the temperature of any part of the applicator contacting the patient must not exceed 41 °C. Under single-fault condition, the limit is 50 °C. | 41 °C (normal); 50 °C (single-fault) |
| 201.15 – Inadvertent output prevention | The equipment must prevent accidental emission of therapeutic ultrasound unless all pre-conditions (e.g., coupling, positioning) are satisfied. A manual reset is required to restart treatment after an interruption. | Hardware and software safeguards |
| 201.16 – Protection against excessive output | Maximum acoustic output must be limited by design to prevent uncontrolled heating or mechanical damage. Limits are based on thermal index (TI) and mechanical index (MI) scaled for therapy. | TI ≤ 6.0; MI ≤ 1.0 (therapy safe limits, though application-specific) |
| 201.17 – User interface and alarms | All critical parameters (power, temperature, dose) must be displayed. Audible and visible alarms must be provided for predefined fault conditions. | Alarm priority levels per IEC 60601-1-8 |
| 201.18 – Cleaning and disinfection | The applicator and accessories must be capable of withstanding repeated cleaning and disinfection according to manufacturer’s instructions without degrading safety or performance. | Test cycles: minimum 100 cleaning cycles |
Additional requirements address electromagnetic compatibility (EMC) per CISPR 11 / IEC 60601-1-2, as well as electrical safety tests such as dielectric strength, leakage current, and protective earth bonding. The standard also places emphasis on software validation for any programmable subsystems, in accordance with IEC 62304.
To demonstrate compliance with CAN CSA C22.2 No. 60601-2-62-15, manufacturers must prepare a technical documentation package that includes:
Certification to CAN CSA C22.2 No. 60601-2-62-15 is typically performed by a recognized testing laboratory accredited by the Standards Council of Canada (SCC), such as CSA Group or Intertek. The process includes both type testing and factory inspection for ongoing compliance. Manufacturers should also be aware that HITU equipment may be classified as a Class III or IV medical device under the Canadian Medical Devices Regulations (SOR/98-282), requiring submission of a medical device license application with evidence of conformity to this standard.
Based on common non-conformities observed during certification, the following areas deserve particular attention:
The adoption of CAN CSA C22.2 No. 60601-2-62-15 ensures that HITU equipment marketed in Canada meets the highest safety and performance benchmarks. Manufacturers should integrate these requirements early in the design process to reduce compliance risk and streamline certification efforts.